Mechanisms of glucose-stimulated GLP-1 and GIP secretion have been intensively investigated as glucose is a potent secretagogue and there is interest in understanding the role of both incretin hormones in the pathology and therapeutics of Type 2 diabetes (T2D). This evidence concerns the gene GCG and type 2 diabetes mellitus.